Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$900M |
| 2 |
Cisco
CSCO
|
+$204M |
| 3 |
Amazon
AMZN
|
+$152M |
| 4 |
Johnson & Johnson
JNJ
|
+$150M |
| 5 |
Brookfield Infrastructure
BIPC
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$430M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$305M |
| 3 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$299M |
| 4 |
Merck
MRK
|
+$291M |
| 5 |
TRTN
Triton International Limited
TRTN
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Financials | 17.15% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Patriot National Bancorp
PNBK
$128M
| $65K | ﹤0.01% |
16,980
-44
| -0.3% | -$238 |
|
3327
FreightCar America
RAIL
$261M
| $64.9K | ﹤0.01% |
24,052
+12,759
| +113% | +$32.2K |
|
3328
Zevia
ZVIA
$116M
| $64.1K | ﹤0.01% |
31,890
-2,766
| -8% | -$5.55K |
|
3329
Nuvation Bio
NUVB
$2.33B
| $63.8K | ﹤0.01% |
42,238
| – | – |
|
|
LITS
3330
Lite Strategy Inc
LITS
$33.6M
| $63.5K | ﹤0.01% |
10,946
| – | – |
|
|
SRT
3331
DELISTED
Startek Inc.
SRT
| $63.5K | ﹤0.01% |
14,389
-25,805
| -64% | -$109K |
|
3332
PharmaCyte Biotech
PMCB
$6.44M
| $63.3K | ﹤0.01% |
29,307
| – | – |
|
3333
Cytosorbents Corp
CTSO
$22M
| $62.7K | ﹤0.01% |
56,570
-22,888
| -29% | -$34K |
|
3334
Vince Holding Corp
VNCE
$80.7M
| $61K | ﹤0.01% |
17,630
-853
| -5% | -$1.23K |
|
3335
Prelude Therapeutics
PRLD
$402M
| $60.9K | ﹤0.01% |
14,305
+3,117
| +28% | +$9.49K |
|
3336
Crexendo
CXDO
$221M
| $59.4K | ﹤0.01% |
+12,239
| New | +$32.1K |
|
|
WHLM
3337
DELISTED
Wilhelmina International, Inc
WHLM
| $58.6K | ﹤0.01% |
14,457
| – | – |
|
3338
Sphere 3D
ANY
$18M
| $57.5K | ﹤0.01% |
+1,732
| New | +$23.6K |
|
3339
Good Times Restaurants
GTIM
$14.8M
| $56.7K | ﹤0.01% |
22,331
| – | – |
|
3340
Vaalco Energy
EGY
$567M
| $55.6K | ﹤0.01% |
12,383
-73,250
| -86% | -$322K |
|
3341
Ocular Therapeutix
OCUL
$1.85B
| $55.3K | ﹤0.01% |
12,389
| – | – |
|
|
BRFS
3342
DELISTED
BRF SA
BRFS
| $55.1K | ﹤0.01% |
19,831
-17,989
| -48% | -$45K |
|
3343
Edesa Biotech
EDSA
$50.6M
| $52K | ﹤0.01% |
+11,333
| New | +$43K |
|
3344
Gain Therapeutics
GANX
$75.1M
| $51.9K | ﹤0.01% |
15,886
-933
| -6% | -$2.59K |
|
3345
Lantern Pharma
LTRN
$33.8M
| $50.6K | ﹤0.01% |
+11,828
| New | +$41.7K |
|
|
UBX
3346
DELISTED
Unity Biotechnology
UBX
| $49.2K | ﹤0.01% |
25,500
-14,219
| -36% | -$26.4K |
|
|
LUMO
3347
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $48.7K | ﹤0.01% |
15,564
| – | – |
|
3348
IZEA Worldwide
IZEA
$59.2M
| $48.5K | ﹤0.01% |
24,150
+10,106
| +72% | +$22.9K |
|
|
KLRS
3349
Kalaris Therapeutics
KLRS
$82.8M
| $48.4K | ﹤0.01% |
3,094
-1,860
| -38% | -$73.3K |
|
3350
DiaMedica Therapeutics
DMAC
$351M
| $48.2K | ﹤0.01% |
16,959
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Dimensional Fund Advisors held 3,516 positions worth $342B, up 12% from $305B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 4.3%. Dimensional Fund Advisors opened 49 new positions and exited 103, leaving the 3,516-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2023 buy was Veralto: 961,231 shares worth $79.1M.
- Dimensional Fund Advisors added most to NVIDIA in Q4 2023, an estimated $900M increase.
- Dimensional Fund Advisors's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $430M.
- Dimensional Fund Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $305M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $342B portfolio in Q4 2023.
- Dimensional Fund Advisors opened 49 new positions and closed 103 in Q4 2023.
- Dimensional Fund Advisors's portfolio value rose 12% quarter-over-quarter to $342B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.